Merck completes tender offer to acquire Cubist
MLex Summary: Drugmaker Merck said Thursday that the company has completed its planned $9.5 billion tender offer for antibiotics maker Cubist Pharmaceuticals.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article